Notably, regardless of whether ischemic or hemorrhagic stroke, plasma B2M is an independent factor of early prognosis after the onset of stroke, and higher B2M levels is associated with a poorer early prognosis (Hu et al. 2019; Wu et al. 2022). The gene discussed is B2M; the disease is hemorrhagic stroke.